Close Menu

NEW YORK (360Dx) – Atomo Diagnostics and Access Bio said today that they would leverage their rapid diagnostic testing technology as part of a collaboration that takes aim at expanding point-of-care HIV testing in global markets.

Atomo will supply its AtomoRapid lateral flow platform for use with an Access Bio rapid test that detects the presence of HIV antibodies in a single drop of blood obtained from a fingertip. The test result can be read in minutes, which is essential to enabling same-day diagnosis and early treatment, the firms said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.